XML 43 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Information (Tables)
 9 Months Ended
Oct. 02, 2021
Segment Information [Abstract]  
Segment Reporting Information by Segment
The following tables set forth business segment information:

   
MOSFETs
    
Diodes
    
Optoelectronic
Components
    
Resistors
    
Inductors
    
Capacitors
    
Corporate / Other*
    
Total
  
Fiscal quarter ended October 2, 2021:
                                            
Net revenues
  
$
175,499
    
$
185,306
    
$
70,750
    
$
181,189
    
$
84,816
    
$
116,103
    
$
-
    
$
813,663
  
                                                                 
Gross profit
  
$
53,868
    
$
46,756
    
$
23,810
    
$
49,729
    
$
26,857
    
$
24,716
    
$
-
    
$
225,736
  
                                                                 
Segment operating income
  
$
43,717
    
$
41,363
    
$
19,708
    
$
43,547
    
$
24,368
    
$
19,913
    
$
-
    
$
192,616
  
                                                                 
Fiscal quarter ended October 3, 2020:
                                                          
Net revenues
  
$
133,976
    
$
123,744
    
$
64,955
    
$
145,362
    
$
79,399
    
$
92,724
    
$
-
    
$
640,160
  
                                                                 
Gross profit
  
$
29,649
    
$
20,843
    
$
21,289
    
$
35,186
    
$
26,597
    
$
18,387
    
$
(242
)
  
$
151,709
  
                                                                 
Segment operating income
  
$
20,148
    
$
15,828
    
$
17,184
    
$
30,127
    
$
24,106
    
$
13,703
    
$
(242
)
  
$
120,854
  

Nine fiscal months ended October 2, 2021:
                                            
Net revenues
  
$
496,659
    
$
517,299
    
$
224,316
    
$
562,513
    
$
253,813
    
$
342,815
    
$
-
    
$
2,397,415
  
                                                                 
Gross Profit
  
$
138,410
    
$
122,929
    
$
73,958
    
$
161,631
    
$
83,288
    
$
77,741
    
$
-
    
$
657,957
  
                                                                 
Segment Operating Income
  
$
108,434
    
$
106,304
    
$
61,070
    
$
142,288
    
$
75,902
    
$
62,462
    
$
-
    
$
556,460
  
                                                                 
Nine fiscal months ended October 3, 2020:
                                                          
Net revenues
  
$
369,813
    
$
363,274
    
$
168,264
    
$
444,982
    
$
218,369
    
$
270,016
    
$
-
    
$
1,834,718
  
                                                                 
Gross Profit
  
$
84,779
    
$
65,265
    
$
47,602
    
$
112,472
    
$
69,836
    
$
53,960
    
$
(4,295
)
  
$
429,619
  
                                                                 
Segment Operating Income
  
$
56,408
    
$
50,064
    
$
35,818
    
$
96,891
    
$
62,129
    
$
39,297
    
$
(4,295
)
  
$
336,312
  

*Amounts reported in Corporate/Other above represent unallocated costs directly related to the COVID-19 pandemic, which are reported as costs of products sold on the consolidated condensed statements of operations.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated

 
Fiscal quarters ended
    
Nine fiscal months ended
  
   
October 2, 2021
    
October 3, 2020
    
October 2, 2021
    
October 3, 2020
  
Reconciliation:
                        
Segment Operating Income
  
$
192,616
    
$
120,854
    
$
556,460
    
$
336,312
  
Restructuring and Severance Costs
    
-
      
-
      
-
      
(743
)
Impact of the COVID-19 Pandemic on Selling, General, and Administrative Expenses
    
-
      
441
      
-
      
871
  
Unallocated Selling, General, and Administrative Expenses
    
(69,095
)
    
(59,805
)
    
(210,303
)
    
(186,742
)
Consolidated Operating Income
  
$
123,521
    
$
61,490
    
$
346,157
    
$
149,698
  
Unallocated Other Income (Expense)
    
(7,106
)
    
(15,766
)
    
(25,405
)
    
(38,100
)
Consolidated Income Before Taxes
  
$
116,415
    
$
45,724
    
$
320,752
    
$
111,598
  
Disaggregation of Revenue
The Company has a broad line of products that it sells to OEMs, EMS companies, and independent distributors.  The distribution of sales by customer type is shown below:

  
Fiscal quarters ended
    
Nine fiscal months ended
  
   
October 2, 2021
    
October 3, 2020
    
October 2, 2021
    
October 3, 2020
  
Distributors
  
$
483,766
    
$
325,695
    
$
1,400,700
    
$
980,703
  
OEMs
    
278,358
      
273,664
      
850,413
      
725,592
  
EMS companies
    
51,539
      
40,801
      
146,302
      
128,423
  
Total Revenue
  
$
813,663
    
$
640,160
    
$
2,397,415
    
$
1,834,718
  
Net revenues were attributable to customers in the following regions:

  
Fiscal quarters ended
    
Nine fiscal months ended
  
   
October 2, 2021
    
October 3, 2020
    
October 2, 2021
    
October 3, 2020
  
Asia
  
$
365,133
    
$
270,451
    
$
1,034,936
    
$
748,160
  
Europe
    
263,650
      
213,296
      
800,801
      
626,276
  
Americas
    
184,880
      
156,413
      
561,678
      
460,282
  
Total Revenue
  
$
813,663
    
$
640,160
    
$
2,397,415
    
$
1,834,718
  
The Company generates substantially all of its revenue from product sales to end customers in the industrial, automotive, telecommunications, computing, consumer products, power supplies, military and aerospace, and medical end markets.  Sales by end market are presented below:

  
Fiscal quarters ended
    
Nine fiscal months ended
  
   
October 2, 2021
    
October 3, 2020
    
October 2, 2021
    
October 3, 2020
  
Industrial
  
$
335,047
    
$
209,473
    
$
927,981
    
$
651,461
  
Automotive
    
240,764
      
216,641
      
743,766
      
552,418
  
Telecommunications
    
24,580
      
27,845
      
72,438
      
91,033
  
Computing
    
58,703
      
51,032
      
183,234
      
151,974
  
Consumer Products
    
43,839
      
33,353
      
128,243
      
76,477
  
Power Supplies
    
42,082
      
29,112
      
119,373
      
86,482
  
Military and Aerospace
    
40,198
      
40,582
      
124,909
      
125,968
  
Medical
    
28,450
      
32,122
      
97,471
      
98,905
  
Total revenue
  
$
813,663
    
$
640,160
    
$
2,397,415
    
$
1,834,718